Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 3.350
- -0.060-1.76%
Close Jan 8 16:00 ET
- 3.350
- 0.0000.00%
Post 20:01 ET
634.80MMarket Cap-7.79P/E (TTM)
3.380High3.215Low920.37KVolume3.370Open3.410Pre Close3.06MTurnover0.68%Turnover RatioLossP/E (Static)189.49MShares4.72552wk High5.94P/B456.33MFloat Cap2.21052wk Low--Dividend TTM136.22MShs Float31.480Historical High--Div YieldTTM4.84%Amplitude0.821Historical Low3.322Avg Price1Lot Size
Arbutus Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -71.25%1.34M | -62.89%1.73M | -77.09%1.53M | -53.51%18.14M | -65.65%2.15M | -21.74%4.66M | -67.34%4.65M | -46.85%6.69M | 255.11%39.02M | 94.79%6.25M |
| Operating revenue | -71.25%1.34M | -62.89%1.73M | -77.09%1.53M | -53.51%18.14M | -65.65%2.15M | -21.74%4.66M | -67.34%4.65M | -46.85%6.69M | 255.11%39.02M | 94.79%6.25M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.68%18.81M | -2.42%23.1M | -13.06%20.72M | -5.93%96.18M | -16.67%22.67M | 10.46%26.01M | -15.88%23.67M | 2.03%23.83M | 23.72%102.24M | 14.23%27.2M |
| Selling and administrative expenses | -22.34%4.54M | 26.20%7.55M | -4.32%5.31M | 26.02%22.48M | 20.05%5.1M | 67.25%5.84M | 15.00%5.98M | 13.49%5.55M | 4.07%17.83M | -7.57%4.25M |
| -General and administrative expense | -22.34%4.54M | 26.20%7.55M | -4.32%5.31M | 26.02%22.48M | 20.05%5.1M | 67.25%5.84M | 15.00%5.98M | 13.49%5.55M | 4.07%17.83M | -7.57%4.25M |
| Research and development costs | -29.23%14.27M | -12.10%15.55M | -15.72%15.4M | -12.69%73.7M | -23.47%17.56M | 0.57%20.17M | -22.88%17.69M | -1.01%18.28M | 28.86%84.41M | 19.45%22.95M |
| Operating profit | 18.18%-17.47M | -12.36%-21.37M | -11.92%-19.18M | -23.43%-78.03M | 2.07%-20.52M | -21.35%-21.35M | -36.83%-19.02M | -59.10%-17.14M | 11.76%-63.22M | -1.70%-20.95M |
| Net non-operating interest income expense | 18.65%1.72M | 39.15%1.8M | 40.28%1.5M | 1,022.10%5.23M | 124.13%1.42M | 446.42%1.45M | 1,600.00%1.29M | 408.36%1.07M | 117.07%466K | 219.62%634K |
| Non-operating interest income | 16.93%1.75M | 25.19%1.83M | 21.85%1.55M | 159.49%5.69M | 55.36%1.47M | 115.27%1.49M | 268.94%1.46M | 697.48%1.27M | 1,625.98%2.19M | 3,043.33%943K |
| Non-operating interest expense | -36.96%29K | -80.12%34K | -77.78%44K | -73.41%459K | -85.76%44K | -89.28%46K | -64.52%171K | -60.87%198K | -39.59%1.73M | -44.82%309K |
| Other net income (expense) | -1,891.96%-3.96M | -134.38%-219K | 28.25%-193K | 98.05%-44K | 86.79%-213K | 15.68%-199K | 410.73%637K | -33.83%-269K | -20.78%-2.26M | -757.98%-1.61M |
| Gain on sale of security | -16.67%5K | -900.00%-8K | -425.00%-13K | 213.64%25K | 450.00%14K | 128.57%6K | -66.67%1K | --4K | -540.00%-22K | ---4K |
| Special income (charges) | -1,836.10%-3.97M | -133.18%-211K | 34.07%-180K | 96.91%-69K | 85.89%-227K | 4.65%-205K | 405.77%636K | -35.82%-273K | -19.28%-2.23M | -733.68%-1.61M |
| -Less：Restructuring and merger&acquisition | 1,836.10%3.97M | 133.18%211K | -34.07%180K | -96.91%69K | -85.89%227K | -4.65%205K | -405.77%-636K | 35.82%273K | 19.28%2.23M | 733.68%1.61M |
| Income before tax | 1.92%-19.72M | -15.81%-19.8M | -9.40%-17.88M | -12.05%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -44.32%-16.34M | 14.74%-65.01M | -2.87%-21.93M |
| Income tax | 0 | 4.44M | 0 | |||||||
| Net income | 1.92%-19.72M | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M |
| Net income continuous Operations | 1.92%-19.72M | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 1.92%-19.72M | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 1.92%-19.72M | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 21.42%-69.46M | -0.17%-21.93M |
| Basic earnings per share | 16.67%-0.1 | -10.00%-0.11 | 0.00%-0.1 | 4.35%-0.44 | 14.29%-0.12 | 0.00%-0.12 | 0.00%-0.1 | 9.09%-0.1 | 44.58%-0.46 | 6.67%-0.14 |
| Diluted earnings per share | 16.67%-0.1 | -10.00%-0.11 | 0.00%-0.1 | 4.35%-0.44 | 14.29%-0.12 | 0.00%-0.12 | 0.00%-0.1 | 9.09%-0.1 | 44.58%-0.46 | 6.67%-0.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.